QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module V — Risk Management Systems

Test your understanding of the concepts covered by GVP Module V: Risk Management Systems.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which statement best reflects the dynamic nature of an RMP?

Once approved, an RMP should remain unchanged unless the product is withdrawn. An RMP should be reassessed when new evidence changes the classification, characterisation, evidence needs or adequacy of measures. An RMP is dynamic only when a new adverse reaction is confirmed. RMP updates are driven exclusively by periodic administrative schedules.

Question 2 of 10 Which operational control is most important when an RMP includes an additional risk-minimisation measure?

Ensuring that the measure is described in the RMP, regardless of operational ownership Assigning responsibility for implementation, defining relevant interfaces and maintaining evidence of delivery and monitoring Delegating all accountability to the healthcare professionals who receive the measure Updating only the RMP while leaving product-information and distribution processes unchanged

Question 3 of 10 Which sequence best represents the lifecycle logic of risk management?

RMP approval, product launch, adverse-event listing, study closure Safety information, risk identification and characterisation, intervention, implementation, effectiveness evaluation and reassessment Signal detection, immediate product withdrawal, retrospective documentation, RMP submission Clinical development, commercial launch, routine distribution, end of pharmacovigilance

Question 4 of 10 A validated signal suggesting a possible increase in a known event has been identified. What is the most appropriate interpretation?

The signal automatically becomes an important identified risk and requires immediate RMP revision. The signal should be assessed and integrated into risk-management decision-making, but it does not automatically determine the final classification or action. The signal is relevant only to case processing and not to the RMP. The signal can be ignored until it appears in a periodic report.

Question 5 of 10 Which governance practice best supports traceability from evidence to risk-management action?

Maintaining separate undocumented decisions within each functional department Linking safety assessments, risk-management decisions, implementation records, effectiveness results, regulatory correspondence and action tracking Recording only the final RMP wording without documenting how it was developed Relying on informal discussions because formal documentation may slow decision-making

Question 6 of 10 Why should risk-management decisions be considered in the context of benefit-risk balance?

Because a serious risk can never justify any risk-minimisation measure. Because the clinical value of the medicine and the feasibility and expected value of interventions influence the appropriate strategy. Because risk management applies only when benefits have already been proven to exceed risks permanently. Because risk minimisation is selected solely according to the availability of a regulatory tool.

Question 7 of 10 Which statement best describes the relationship between a risk-management system and an RMP?

The RMP is the operational system, while the risk-management system is only a regulatory summary. The risk-management system comprises lifecycle activities and controls, while the RMP documents the relevant planned approach. The RMP replaces the need for effectiveness evaluation once it has been approved. The risk-management system applies only before authorisation, whereas the RMP applies after authorisation.

Question 8 of 10 A company outsources an effectiveness survey for an additional risk-minimisation measure. Which statement is most appropriate?

The vendor assumes all regulatory and pharmacovigilance accountability. The MAH should maintain oversight and define responsibilities, data flows, quality controls and escalation mechanisms. Vendor activities do not need to be reflected in the risk-management system if the final report is received. The QPPV must conduct the survey personally to retain oversight.

Question 9 of 10 A new study substantially reduces uncertainty about a previously suspected adverse reaction but does not support an association with the medicine. What should a mature risk-management system do?

Automatically escalate the concern to an important identified risk because it was previously listed. Reassess the concern and consider whether its classification, evidence needs and management measures remain appropriate. Keep the strategy unchanged because risk management can respond only to increased risk. Delete all related records without documenting the scientific rationale.

Question 10 of 10 Which inspection finding most clearly indicates a divergence between the RMP and operational reality?

The RMP contains a scientific rationale for excluding a concern. The RMP describes an educational programme, but there are no records showing that it was implemented, monitored or evaluated. The organisation uses multidisciplinary input for important safety decisions. The organisation reassesses the strategy after new evidence becomes available.

Knowledge Assessment: GVP Module V — Risk Management Systems

Cookie Settings